Linezolid IP 600mg

Wyzolid 600 Tablet, containing Linezolid IP 600 mg, is a highly effective, broad-spectrum antibiotic manufactured by Amista Labs, a trusted name in the Indian pharmaceutical industry. Designed to combat serious and resistant bacterial infections, Wyzolid 600 Tablet plays a vital role in modern antimicrobial therapy, especially where conventional antibiotics fail to deliver desired results.

Linezolid belongs to the oxazolidinone class of antibiotics, known for its strong action against Gram-positive bacteria, including drug-resistant strains. Amista Labs ensures that Wyzolid 600 Tablet is produced in WHO-GMP, GLP, and ISO 9001:2015 certified facilities, guaranteeing high quality, safety, and therapeutic efficacy.

Composition

• Linezolid IP 600 mg

Each film-coated tablet contains Linezolid IP 600 mg, formulated for optimal absorption and consistent clinical outcomes.

Mechanism of Action: How Wyzolid-600 Works

Linezolid, the active ingredient in Wyzolid 600, belongs to the oxazolidinone class of antibiotics. Unlike many other antibiotics that attack the bacterial cell wall or DNA, Linezolid works by inhibiting bacterial protein synthesis at a very early stage.

Specifically, it binds to the bacterial 23S ribosomal RNA of the 50S subunit, preventing the formation of the functional 70S initiation complex. This unique mechanism of action means there is no cross-resistance with other drug classes (such as penicillins, cephalosporins, or aminoglycosides), making Wyzolid 600 highly effective against bacteria that have developed resistance to other treatments.

Key Indications and Usage

Wyzolid-600 is indicated for the treatment of infections caused by susceptible Gram-positive bacteria. It is a “reserve” antibiotic, often deployed when first-line treatments fail.

1. Multidrug-Resistant Infections The primary strength of Wyzolid 600 is its efficacy against pathogens that are resistant to multiple other drugs. It is a lifesaver in complex medical cases where standard antibiotics are rendered ineffective.

2. MRSA (Methicillin-Resistant Staphylococcus Aureus) MRSA is a “superbug” known for causing difficult-to-treat infections in humans. Wyzolid 600 is clinically proven to treat MRSA infections effectively, preventing the spread of the bacteria and aiding rapid recovery.

3. VRE (Vancomycin-Resistant Enterococci) Enterococci are bacteria often found in hospitals. When they become resistant to Vancomycin (a strong antibiotic), treatment options become scarce. Linezolid is one of the few drugs capable of tackling VRE infections, specifically Enterococcus faecium.

4. Pneumonia Wyzolid 600 is highly effective in treating both:

• Nosocomial Pneumonia (Hospital-Acquired): Infections acquired during hospital stays, often caused by resistant Staphylococcus aureus or Streptococcus pneumoniae.

• Community-Acquired Pneumonia (CAP): Severe lung infections contracted outside of the healthcare system.

5. Complicated Skin and Soft Tissue Infections This includes diabetic foot infections, surgical wound infections, and deep-tissue abscesses. The drug penetrates well into soft tissues, ensuring the infection is treated at the source.

Quality Assurance: The Amista Labs Promise

At Amista Labs, quality is not just a standard; it is a commitment. Wyzolid 600 is manufactured under stringent quality control measures.

• WHO-GMP Certified: Ensuring the product is consistently produced and controlled according to quality standards.

• GLP (Good Laboratory Practice): Guarantees the non-clinical safety data is reliable.

• ISO 9001:2015: A testament to our robust quality management systems.

• Premium Packaging: The product comes in Alu-Alu packaging, which provides the highest level of protection against moisture, oxygen, and light, ensuring the stability and potency of the tablet until consumption.

Dosage and Administration

• Strength: Each film-coated tablet contains 600 mg of Linezolid.

• Dosage: The dosage and duration of treatment depend on the severity of the infection and the patient’s medical history. It is strictly a prescription drug and must be taken under the supervision of a registered medical practitioner.

• Administration: It can be taken with or without food.